Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

Overview of attention for article published in Inflammatory Bowel Diseases, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 17 X users

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 91 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 18 X posts from 17 X users, with an upper bound of 50,705 followers.

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry https://t.co/HIrsj65yyf #hfuenla @HUFuenlabrada #Digestivo Inflamm Bowel Dis. 2020;26:606-16.

08 Apr 2021

Reply Repost Favourite

Dr. Casanova and colleagues analyze the effectiveness and safety of treatment with a second and third anti-TNF drug after intolerance to or failure of a previous anti-TNF agent in patients with #IBD: Results from the ENEIDA registry. https://t.co/xo3ohg2gc

29 Apr 2020

Reply Repost Favourite

RT @EIILaPrincesa: Se acaba de publicar en #IBD un nuevo estudio ENEIDA liderado por @EIILaPrincesa que evalúa la efectividad y seguridad d…

25 Sep 2019

Reply Repost Favourite

RT @EIILaPrincesa: Se acaba de publicar en #IBD un nuevo estudio ENEIDA liderado por @EIILaPrincesa que evalúa la efectividad y seguridad d…

24 Sep 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.